Variant report

Variant	esv3372885
Chromosome Location	chr1:10925565-10927613
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:23)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:23 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:10927411..10929903-chr1:10960980..10963469,2	MCF-7	breast:
2	chr1:10911727..10913949-chr1:10927458..10930368,2	K562	blood:
3	chr1:10751694..10755124-chr1:10925813..10928871,3	MCF-7	breast:
4	chr1:10590066..10590945-chr1:10927189..10927789,2	K562	blood:
5	chr1:10562142..10564951-chr1:10926770..10929049,2	K562	blood:
6	chr1:10576160..10578872-chr1:10926632..10929593,2	MCF-7	breast:
7	chr1:10919663..10923359-chr1:10925488..10928766,3	MCF-7	breast:
8	chr1:10574408..10575004-chr1:10926842..10927727,2	K562	blood:
9	chr1:10926420..10929831-chr1:10932404..10934606,3	K562	blood:
10	chr1:10892514..10895346-chr1:10924391..10927017,2	K562	blood:
11	chr1:10554756..10555464-chr1:10926875..10927459,2	K562	blood:
12	chr1:10568670..10571119-chr1:10926842..10928478,2	K562	blood:
13	chr1:10567095..10568153-chr1:10926865..10927880,8	K562	blood:
14	chr1:10923927..10926846-chr1:10929418..10932147,3	K562	blood:
15	chr1:10754807..10756455-chr1:10925799..10928452,2	MCF-7	breast:
16	chr1:10489961..10490892-chr1:10926816..10927795,3	K562	blood:
17	chr1:10923092..10926846-chr1:10929418..10932147,4	K562	blood:
18	chr1:10895615..10898736-chr1:10923813..10928307,5	K562	blood:
19	chr1:10914701..10916708-chr1:10923191..10926876,3	MCF-7	breast:
20	chr1:10926964..10929247-chr1:10959901..10962873,4	MCF-7	breast:
21	chr1:10752227..10753991-chr1:10926922..10928500,5	MCF-7	breast:
22	chr1:10834395..10836864-chr1:10924588..10926735,2	MCF-7	breast:
23	chr1:10925966..10930455-chr1:10932404..10937595,5	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TARDBP-9	chr1:10925409-10925611	NONHSAT000869

No data

Variant related genes	Relation type
ENSG00000130940	chromatin interactions
ENSG00000175279	chromatin interactions
ENSG00000271989	chromatin interactions
ENSG00000251503	chromatin interactions

Extended variants
information (count: 62 )
Associated
traits (count: 110 )

Variant overlapped rSNPs/rCNVs (count:62 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs60400758	chr1:10925576-10925577	Bivalent Enhancer Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
2	rs555768484	chr1:10925578-10925579	Bivalent Enhancer Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
3	rs372442639	chr1:10925614-10925615	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs570882098	chr1:10925643-10925644	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs139978838	chr1:10925651-10925652	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs113454483	chr1:10925710-10925711	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs573357411	chr1:10925728-10925729	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs186317209	chr1:10925729-10925730	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs528817408	chr1:10925735-10925736	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs190822508	chr1:10925737-10925738	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs182805854	chr1:10925772-10925773	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs374555059	chr1:10925788-10925789	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs187412826	chr1:10925789-10925790	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs563055309	chr1:10925832-10925833	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs144825925	chr1:10925835-10925836	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs577934563	chr1:10925836-10925837	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs142370825	chr1:10925867-10925868	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs57465358	chr1:10925877-10925878	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs545182079	chr1:10925927-10925928	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs560587941	chr1:10926056-10926057	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs527782656	chr1:10926098-10926099	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs548571716	chr1:10926126-10926127	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs2790694	chr1:10926127-10926128	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs371991010	chr1:10926234-10926235	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs560726489	chr1:10926360-10926361	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs531523057	chr1:10926389-10926390	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs549630429	chr1:10926390-10926391	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs570916888	chr1:10926399-10926400	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs202186587	chr1:10926490-10926491	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs538580073	chr1:10926512-10926513	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs1281002	chr1:10926560-10926561	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs527299547	chr1:10926593-10926594	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs552118915	chr1:10926597-10926598	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs369394796	chr1:10926622-10926623	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs535951699	chr1:10926647-10926648	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs556026777	chr1:10926763-10926764	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs574260585	chr1:10926802-10926803	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs190803569	chr1:10926827-10926828	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs556855291	chr1:10926832-10926833	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs577962404	chr1:10926892-10926893	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs112672852	chr1:10926906-10926907	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs34896200	chr1:10926916-10926917	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs36047809	chr1:10926966-10926967	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs542684256	chr1:10926968-10926969	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs565387120	chr1:10926975-10926976	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs531360236	chr1:10927019-10927020	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs549665251	chr1:10927026-10927027	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs567904938	chr1:10927079-10927080	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs575688258	chr1:10927095-10927096	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs35236487	chr1:10927117-10927118	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:110)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Follicular lymphoma	18703704	CNVD
Lung cancer	22429812	CNVD
Epilepsy	22118685	CNVD
Schizophrenia	22118685	CNVD
Ovarian cancer	21720365	CNVD
Developmental delay	19490664	CNVD
Ewing''s sarcoma	21437220	CNVD
Prader-willi syndrome	18797701	CNVD
periventricular nodular heterotopia	20648244	CNVD
1p36 deletion syndrome	22283845	CNVD
Cervical cancer	21062161	CNVD
Cancer	21183584	CNVD
Follicular lymphoma	20505157	CNVD
Neuroblastoma	18923524	CNVD
Retinoblastoma	22278416	CNVD
Mental retardation	20152051	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Astrocytoma	17934521	CNVD
Glioblastoma	20031968	CNVD
Acute myeloid leukemia	18000384	CNVD
Glioblastoma multiforme	16951158	CNVD
Neuroblastoma	18574593	CNVD
Glioblastoma multiforme	17369134	CNVD
Autism	18414403	CNVD
Breast cancer	17001317	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Myoepithelioma	18604193	CNVD
Wilms tumour	19047088	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Hepatocellular carcinoma	16750200	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Metanephric adenoma	20802469	CNVD
Soft tissue tumor	16732325	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Colorectal cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Coronary Disease	20032323	CNVD
Prostate cancer	21965145	CNVD
Stargardt''s disease	17277736	CNVD
Neuroblastoma	17897457	CNVD
Uveal melanoma	21693616	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Neuroblastoma	21484798	CNVD
Non-syndromic sensorineural hearing loss	22290220	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	21264507	CNVD
Acute myeloid leukemia	16864856	CNVD
Astrocytoma	17387387	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	17387387	CNVD
Oligodendroglial tumors	17285580	CNVD
Neuroblastoma	17535989	CNVD
Pheochromocytoma	17535989	CNVD
Prostate cancer	16705090	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Neuroblastoma	17533364	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Chronic myeloid leukemia	21384125	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Neuroblastoma	18923191	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Non-small cell lung cancer	21385341	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Chordoma	21602918	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Multiple myeloma	16461302	CNVD
Glioblastoma multiforme	21138945	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Ovarian neoplasms	16753589	CNVD
Neuroblastoma	19287153	CNVD
Hepatocellular carcinoma	18929564	CNVD
Melanoma	17363583	CNVD
renal disease	17924346	CNVD
Uveal melanoma	20484589	CNVD
Multiple myeloma	16616336	CNVD
Glioblastoma multiforme	22286061	CNVD
Myelofibrosis	22110671	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	20808228	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:360 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:10918600-10926600	Weak transcription	Esophagus	oesophagus
2	chr1:10920000-10926800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
3	chr1:10920200-10926800	Bivalent Enhancer	Fetal Muscle Leg	muscle
4	chr1:10921200-10926600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
5	chr1:10921600-10926000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
6	chr1:10921600-10926800	Weak transcription	Gastric	stomach
7	chr1:10922000-10926200	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr1:10922200-10925600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr1:10922800-10926800	Weak transcription	Right Atrium	heart
10	chr1:10923000-10926800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
11	chr1:10923600-10925800	Weak transcription	Right Ventricle	heart
12	chr1:10923600-10926600	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr1:10923800-10926000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
14	chr1:10924400-10926800	Weak transcription	Psoas Muscle	Psoas
15	chr1:10924600-10925600	Bivalent Enhancer	Brain Germinal Matrix	brain
16	chr1:10924600-10926000	Weak transcription	Fetal Heart	heart
17	chr1:10924800-10926600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
18	chr1:10924800-10926800	Weak transcription	Liver	Liver
19	chr1:10925200-10926600	Weak transcription	Pancreas	Pancrea
20	chr1:10925400-10926000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
21	chr1:10925600-10925800	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
22	chr1:10925600-10925800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
23	chr1:10925600-10926600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr1:10925800-10926000	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr1:10925800-10926000	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
26	chr1:10925800-10926000	Bivalent Enhancer	Fetal Lung	lung
27	chr1:10925800-10926000	Enhancers	Right Ventricle	heart
28	chr1:10925800-10926200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
29	chr1:10925800-10926400	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
30	chr1:10925800-10926400	Bivalent Enhancer	Brain Germinal Matrix	brain
31	chr1:10925800-10926600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
32	chr1:10925800-10926600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
33	chr1:10925800-10926600	Bivalent Enhancer	Fetal Stomach	stomach
34	chr1:10925800-10928000	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
35	chr1:10926000-10926200	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
36	chr1:10926000-10926200	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
37	chr1:10926000-10926200	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
38	chr1:10926000-10926200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
39	chr1:10926000-10926200	Enhancers	Brain Angular Gyrus	brain
40	chr1:10926000-10926200	Bivalent/Poised TSS	Fetal Kidney	kidney
41	chr1:10926000-10926400	Weak transcription	Right Ventricle	heart
42	chr1:10926000-10926600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
43	chr1:10926000-10926600	Enhancers	Breast Myoepithelial Primary Cells	Breast
44	chr1:10926000-10926600	Enhancers	Primary hematopoietic stem cells	blood
45	chr1:10926000-10926600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
46	chr1:10926000-10926800	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
47	chr1:10926000-10926800	Enhancers	Skeletal Muscle Female	skeletal muscle
48	chr1:10926000-10927800	Active TSS	H9 Cell Line	embryonic stem cell
49	chr1:10926000-10927800	Bivalent Enhancer	Primary B cells from peripheral blood	blood
50	chr1:10926000-10927800	Enhancers	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links